Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models

Respiratory syncytial virus (RSV) causes a high disease burden in older adults. An effective vaccine for this RSV-primed population may need to boost/elicit robust RSV-neutralizing antibody responses and recall/induce RSV-specific T cell responses. To inform the selection of the vaccine formulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouzya, Badiaa, Rouxel, Ronan Nicolas, Sacconnay, Lionel, Mascolo, Romuald, Nols, Laurence, Quique, Stéphanie, François, Loïc, Atas, Anne, Warter, Lucile, Dezutter, Nancy, Lorin, Clarisse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541443/
https://www.ncbi.nlm.nih.gov/pubmed/37773185
http://dx.doi.org/10.1038/s41541-023-00729-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541443/
https://www.ncbi.nlm.nih.gov/pubmed/37773185
http://dx.doi.org/10.1038/s41541-023-00729-4

Ejemplares similares